Clinical characteristics and treatment advances in isolated axillary lymph node recurrence after breast cancer surgery

Isolated axillary recurrence (AR) after breast cancer surgery is one of the critical factors influencing patients’ prognosis. With advancements in diagnostic and therapeutic techniques, the clinical understanding of AR has progressively deepened. However, due to the low incidence of AR, systematic s...

Full description

Saved in:
Bibliographic Details
Main Author: DU Xinyue, WU Siyu, LIU Guangyu
Format: Article
Language:English
Published: Editorial Office of China Oncology 2025-06-01
Series:Zhongguo aizheng zazhi
Subjects:
Online Access:https://www.china-oncology.com/fileup/1007-3639/PDF/1752457584466-1372589941.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849412448757481472
author DU Xinyue, WU Siyu, LIU Guangyu
author_facet DU Xinyue, WU Siyu, LIU Guangyu
author_sort DU Xinyue, WU Siyu, LIU Guangyu
collection DOAJ
description Isolated axillary recurrence (AR) after breast cancer surgery is one of the critical factors influencing patients’ prognosis. With advancements in diagnostic and therapeutic techniques, the clinical understanding of AR has progressively deepened. However, due to the low incidence of AR, systematic studies on its clinical features remain limited. High-quality clinical trials, such as ACOSOG Z0011 and AMAROS, have demonstrated that in patients with varying statuses of sentinel lymph node, axillary lymph node dissection (ALND) and sentinel lymph node dissection (SLND) provide comparable control of AR. In recent years, the trend towards de-escalation axillary surgery has advanced the development of less invasive techniques such as targeted axillary lymph node dissection. The SOUND trial further confirmed the safety and feasibility of omitting axillary surgery in patients with tumors ≤2 cm. In addition, a series of clinical studies have identified a variety of potential high-risk factors, including patient age, number of positive lymph nodes, high Ki-67 proliferation, extranodal extension, and axillary soft tissue infiltration. However, there is no broad consensus regarding the association of these factors with AR. This review comprehensively summarized the clinical characteristics, risk factors and personalized management strategies of AR, with an emphasis on the impact of different axillary surgical approaches, radiotherapy and systemic therapy on the AR risk. In addition, more high-quality clinical studies are urgently needed to further clarify prognostic factors and optimize individualized treatment strategies, so as to provide more precise management for patients.
format Article
id doaj-art-efcca4fdd14b431db119461bbd1d48cb
institution Kabale University
issn 1007-3639
language English
publishDate 2025-06-01
publisher Editorial Office of China Oncology
record_format Article
series Zhongguo aizheng zazhi
spelling doaj-art-efcca4fdd14b431db119461bbd1d48cb2025-08-20T03:34:26ZengEditorial Office of China OncologyZhongguo aizheng zazhi1007-36392025-06-0135659260010.19401/j.cnki.1007-3639.2025.06.009Clinical characteristics and treatment advances in isolated axillary lymph node recurrence after breast cancer surgeryDU Xinyue, WU Siyu, LIU Guangyu01. Shanghai Medical College, Fudan University, Shanghai 200032, China;2. Department of Breast Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, ChinaIsolated axillary recurrence (AR) after breast cancer surgery is one of the critical factors influencing patients’ prognosis. With advancements in diagnostic and therapeutic techniques, the clinical understanding of AR has progressively deepened. However, due to the low incidence of AR, systematic studies on its clinical features remain limited. High-quality clinical trials, such as ACOSOG Z0011 and AMAROS, have demonstrated that in patients with varying statuses of sentinel lymph node, axillary lymph node dissection (ALND) and sentinel lymph node dissection (SLND) provide comparable control of AR. In recent years, the trend towards de-escalation axillary surgery has advanced the development of less invasive techniques such as targeted axillary lymph node dissection. The SOUND trial further confirmed the safety and feasibility of omitting axillary surgery in patients with tumors ≤2 cm. In addition, a series of clinical studies have identified a variety of potential high-risk factors, including patient age, number of positive lymph nodes, high Ki-67 proliferation, extranodal extension, and axillary soft tissue infiltration. However, there is no broad consensus regarding the association of these factors with AR. This review comprehensively summarized the clinical characteristics, risk factors and personalized management strategies of AR, with an emphasis on the impact of different axillary surgical approaches, radiotherapy and systemic therapy on the AR risk. In addition, more high-quality clinical studies are urgently needed to further clarify prognostic factors and optimize individualized treatment strategies, so as to provide more precise management for patients.https://www.china-oncology.com/fileup/1007-3639/PDF/1752457584466-1372589941.pdf|breast cancer|regional lymph node recurrence|breast cancer prognosis
spellingShingle DU Xinyue, WU Siyu, LIU Guangyu
Clinical characteristics and treatment advances in isolated axillary lymph node recurrence after breast cancer surgery
Zhongguo aizheng zazhi
|breast cancer|regional lymph node recurrence|breast cancer prognosis
title Clinical characteristics and treatment advances in isolated axillary lymph node recurrence after breast cancer surgery
title_full Clinical characteristics and treatment advances in isolated axillary lymph node recurrence after breast cancer surgery
title_fullStr Clinical characteristics and treatment advances in isolated axillary lymph node recurrence after breast cancer surgery
title_full_unstemmed Clinical characteristics and treatment advances in isolated axillary lymph node recurrence after breast cancer surgery
title_short Clinical characteristics and treatment advances in isolated axillary lymph node recurrence after breast cancer surgery
title_sort clinical characteristics and treatment advances in isolated axillary lymph node recurrence after breast cancer surgery
topic |breast cancer|regional lymph node recurrence|breast cancer prognosis
url https://www.china-oncology.com/fileup/1007-3639/PDF/1752457584466-1372589941.pdf
work_keys_str_mv AT duxinyuewusiyuliuguangyu clinicalcharacteristicsandtreatmentadvancesinisolatedaxillarylymphnoderecurrenceafterbreastcancersurgery